BioCryst Pharmaceuticals | BCRX - النقدية وما يعادلها





النقدية وما يعادلها تغيير تاريخ
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Chugai Pharma JPY 426.6B 29.83B 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
DBV Technologies USD 194.17M 124.33M 2025-12
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.3B 303M 2025-09
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Novavax USD 240.63M 27.39M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Ultragenyx Pharmaceutical USD 421M 218.49M 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03